James H. Sabry, Executive Chairman at CYTOKINETICS INC (CYTK), sold 7,000 shares at $6.31 ($45K) on 2007-06-11, disclosed to the SEC on 2007-06-12.
Scheduled sale ($45k) by Executive Chairman under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $6.31 | 755 | $5K | 10.6% |
| 2 | $6.32 | 100 | $632 | 1.4% |
| 3 | $6.33 | 100 | $633 | 1.4% |
| 4 | $6.35 | 2,500 | $16K | 35.5% |
| 5 | $6.38 | 100 | $638 | 1.4% |
| 6 | $6.39 | 311 |
| $2K |
| 4.4% |
| 7 | $6.43 | 300 | $2K | 4.3% |
| 8 | $6.45 | 2,277 | $15K | 32.8% |
| 9 | $6.46 | 200 | $1K | 2.9% |
| 10 | $6.48 | 357 | $2K | 5.2% |
| Total | $6.39 avg | 7,000 | $45K | 100% |
| Filing → |
| CYTK | SELL | 2010-05-14 | $30K | — | Filing → |
| CYTK | SELL | 2010-04-28 | $32K | — | Filing → |
| CYTK | SELL | 2010-04-01 | $32K | — | Filing → |